PO59 EFFICACY AND SAFETY OF EVEROLIMUS PLUS EXEMESTANE COMBINATION THERAPY VERSUS MONOTHERAPY WITH EVEROLIMUS OR CAPECITABINE IN HR+, HER2− BREAST CANCER: A MULTI-CENTER, OPEN-LABEL, PHASE 2 TRIAL BOLERO-6

✍ Scribed by de Boer, Richard; Jerusalem, Guy; Hurvitz, Sara; Ejlertsen, Bent; El-Hashimy, Mona; Feng, Wentao; Taran, Tetiana; Burris, Howard

• Book ID: 122170240
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 53 KB
• Volume: 22
• Category: Article
• ISSN: 0960-9776
• DOI: 10.1016/S0960-9776(13)70073-0